Multi-omics Market: By Type (Single-cell Multi-omics and Bulk Multi-omics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics Platforms), By Indication (Cell Biology, Oncology, Neurology, and Immunology), and By Geography (North America, Europe, Asia Pacific, Latin America, and MEA), and Forecast to 2030.

Purchase Option

$ 4400
$ 6600
$ 8900

The global multi-omics market was valued at USD 2,619.5 million in 2024 and is expected to reach USD 5,974.3 million by 2030, at a CAGR of 12.5% during the forecast period 2024 – 2030. The multi-omics market refers to the sector within biotechnology and bioinformatics that involves the integration and analysis of multiple "omics" data types, such as genomics, proteomics, metabolomics, transcriptomics, and epigenomics. These approaches allow researchers to gain a comprehensive understanding of biological systems by studying various molecular levels simultaneously. The market growth can be attributed to the increasing demand for single-cell multi-omics and advancements in omics technologies. Moreover, the categories, such as genomics, proteomics, metabolomics, and transcriptomics are gaining momentum for healthcare purposes. The COVID-19 pandemic had a positive impact on the industry. The multi-omics approaches have been considered for COVID-19 diagnosis and insights. Various studies and research were conducted to understand the multi-omics role in the COVID-19 diagnosis. For instance, according to the study published by the MDPI in September 2021, multi-omics technology can provide significant new insights to understand COVID-19. Additionally, the emphasis on personalized medicine encourages healthcare providers and researchers to utilize multi-omics technologies to a greater extent. Sharing data is crucial for advancing collaborative multi-omics research but concerns about patient privacy and regulatory compliance can impose limits. This might impede research collaboration and limit access to multi-omics datasets. Regulatory shifts can occur unexpectedly and frequently, necessitating constant monitoring and adaptation by market players. This dynamic environment introduces uncertainty into their operations.

Recent Developments of the Market:

  • In January 2024, BD announced the collaboration with Hamilton Company. Through this collaboration, the company focuses on developing robotics-compatible and automated applications reagent kits to standardize and reduce human error in large-scale single-cell multi-omics experiments.
  • In January 2024, Thermo Fisher Scientific Inc. collaborated with Akoya Biosciences, Inc. for a license and distribution agreement to deliver a combined solution for spatial multi-omics workflows. The agreement enables a simplified process for whole-slide, multiomic imaging. This combined approach provides a more comprehensive understanding of cell phenotypes and conditions by examining protein and RNA, which is crucial for fields in cancer research.
  • In November 2023, Illumina introduced an advanced liquid biopsy assay designed to facilitate comprehensive genomic profiling of solid tumours.

Multi-omics Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

12.5%

Largest Market

North America

Fastest Growing Market

Asia pacific
Multi-omics Market Dynamics

Advanced omics technologies with high-throughput capabilities have significantly lowered the expenses associated with data generation. This cost reduction has made multi-omics research more accessible to a broader spectrum of researchers, institutions, and businesses. Consequently, there's a surge in market participants, which stimulates innovation and competitiveness. This detailed approach is essential for pinpointing potential biomarkers and therapeutic targets. The decreased entry barriers have nurtured a flourishing landscape of start-ups and firms focusing on omics technologies and services. These dynamics are projected to drive future demand. Multi-omics data can provide a detailed understanding of a patient's genetic predispositions, biomarker profiles, and disease risks. This integration boosts the demand for multi-omics technologies and services. The demand for these data in personalized medicine has created opportunities for innovative start-ups and established companies to provide specialized services and technologies. Thus, these factors will drive the expansion of the market in the upcoming years.

Multi-omics Market Segmentation

By Type
  • Single-cell multi-omics
  • Bulk multi-omics
By Indication
  • Cell Biology
  • Oncology
  • Neurology
  • Immunology
By Platform
  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms

Frequently Asked Questions

The global multi-omics market was valued at USD 2,619.5 million in 2024 and is expected to reach USD 5,974.3 million by 2030, at a CAGR of 12.5% during the forecast period 2024 – 2030.

The leading players in the multi-omics market are Thermo Fisher Scientific Inc., Illumina, Inc., PerkinElmer Inc., Shimadzu Corporation, Bruker, Agilent Technologies, Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Waters Corporation, Roche Holding AG, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Eurofins Scientific, and BGI Group.

“North America” had the largest share in the multiomics market.

The major driver for the multiomics market is high demand in pharmaceuticals.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
1. Executive Summary
2. Global Multi-omics Market Introduction 
2.1.Global Multi-omics Market  - Taxonomy
2.2.Global Multi-omics Market  - Definitions
2.2.1.Type 
2.2.2.Indication
2.2.3.Platform
2.2.4.Region
3. Global Multi-omics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Multi-omics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Multi-omics Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Single-cell multi-omics
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Bulk multi-omics
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Multi-omics Market  By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Cell Biology
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Oncology
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Neurology
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Immunology
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Multi-omics Market  By Platform, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Genomics
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Transcriptomics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Proteomics
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Metabolomics
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Integrated Omics Platforms
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Multi-omics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Single-cell multi-omics
9.1.2.Bulk multi-omics
9.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cell Biology
9.2.2.Oncology
9.2.3.Neurology
9.2.4.Immunology
9.3.  Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Genomics
9.3.2.Transcriptomics
9.3.3.Proteomics
9.3.4.Metabolomics
9.3.5.Integrated Omics Platforms
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Single-cell multi-omics
10.1.2.Bulk multi-omics
10.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cell Biology
10.2.2.Oncology
10.2.3.Neurology
10.2.4.Immunology
10.3.  Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Genomics
10.3.2.Transcriptomics
10.3.3.Proteomics
10.3.4.Metabolomics
10.3.5.Integrated Omics Platforms
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Single-cell multi-omics
11.1.2.Bulk multi-omics
11.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cell Biology
11.2.2.Oncology
11.2.3.Neurology
11.2.4.Immunology
11.3.  Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Genomics
11.3.2.Transcriptomics
11.3.3.Proteomics
11.3.4.Metabolomics
11.3.5.Integrated Omics Platforms
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Single-cell multi-omics
12.1.2.Bulk multi-omics
12.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cell Biology
12.2.2.Oncology
12.2.3.Neurology
12.2.4.Immunology
12.3.  Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Genomics
12.3.2.Transcriptomics
12.3.3.Proteomics
12.3.4.Metabolomics
12.3.5.Integrated Omics Platforms
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Multi-omics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Single-cell multi-omics
13.1.2.Bulk multi-omics
13.2.  Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cell Biology
13.2.2.Oncology
13.2.3.Neurology
13.2.4.Immunology
13.3.  Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Genomics
13.3.2.Transcriptomics
13.3.3.Proteomics
13.3.4.Metabolomics
13.3.5.Integrated Omics Platforms
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Thermo Fisher Scientific Inc.
14.2.2.Illumina, Inc.
14.2.3.PerkinElmer Inc.
14.2.4.Shimadzu Corporation
14.2.5.Bruker
14.2.6.Agilent Technologies, Inc.
14.2.7.Qiagen N.V.
14.2.8.Bio-Rad Laboratories Inc.
14.2.9.Waters Corporation
14.2.10.Roche Holding AG
14.2.11.Oxford Nanopore Technologies Ltd.
14.2.12.Pacific Biosciences of California Inc.
14.2.13.Eurofins Scientific
14.2.14.BGI Group
15. Research Methodology 
16. Appendix and Abbreviations 
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Bruker
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Bio-Rad Laboratories Inc.
  • Waters Corporation
  • Roche Holding AG
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California Inc.
  • Eurofins Scientific
  • BGI Group

Adjacent Markets